This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.

This information was originally presented at the NCCN 12th Annual Congress: Hematologic Malignancies™ held in San Francisco, California, on October 6-7, 2017.

This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.

Join Jeremy Abramson, MD and Jeffrey Barnes, MD as they present their multidisciplinary expertise on a range of cases pertaining to CLL and SLL.

Join Amir Behdad, MD and Leo Gordon, MD as they present their multidisciplinary expertise on a range of cases pertaining to mantle cell lymphoma.

Join Jeremy Abramson, MD and Jeffrey Barnes, MD as they present their multidisciplinary expertise on a range of cases pertaining to CLL and SLL.

No, But the Apoptosis Pathway Has Been Activated

Join Amir Behdad, MD and Leo Gordon, MD as they present their multidisciplinary expertise on a range of cases pertaining to mantle cell lymphoma.

Mantle cell lymphoma (MCL) is a heterogenous disease with historically relative poor outcomes. However, new treatment strategies seem to be improving the prognosis for patients.

The NCCN 2014 Nursing Program Webinar Series: Advancing Oncology Nursing™ will provide the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.